Taurine and aneurysmal subarachnoid hemorrhage prognosis

Area of Science:

• Biochemistry
• Neurology
• Cardiology

Background:

• Taurine has known cardiovascular benefits, including increased cardiac muscle strength and arrhythmia prevention.
• Despite established benefits, taurine's role in critical conditions remains debated.
• Aneurysmal subarachnoid hemorrhage (aSAH) carries a significant risk of mortality and long-term disability.

Purpose of the Study:

• To investigate the potential of plasma taurine levels as a prognostic marker in patients with aSAH.
• To determine if taurine levels can predict mortality or a vegetative state in aSAH patients, particularly those with initially good neurological grades.

Main Methods:

• Analysis of plasma taurine levels in patients diagnosed with aSAH.
• Correlation of taurine levels with patient outcomes, including mortality and neurological status at hospital discharge.
• Comparison of outcomes in patients with varying neurological grades at admission.

Main Results:

• Elevated plasma taurine levels were associated with an increased risk of death or a vegetative state in aSAH patients.
• This association was observed even in patients who presented with a good neurological grade, challenging typical prognostic expectations.
• Approximately one in four patients with initially good neurological grades experienced poor outcomes (death or vegetative state).

Conclusions:

• Plasma taurine may serve as a critical prognostic biomarker for aSAH.
• High taurine levels could identify high-risk patients who might otherwise be expected to have a favorable prognosis.
• Taurine's role in aSAH pathophysiology warrants further investigation to explain this prognostic paradox.